Popular on Rezul
- Elmington Residential Acquires 260-Unit Workforce Housing Community in Atlanta, GA - 386
- Mesa West Capital Provides $61.5 Million Loan to Finance Silicon Valley Office Property - 325
- Okaloosa Recovery Centers Combine Oct. 26: What Niceville, Shalimar and FWB Homeowners Should Know - 233
- Market Report Q3 2026| Houston Citywide Office - 210
- Bacchus Wine & Spirits and Michelin Guide–Recommended Ethel's Fancy to Host Exclusive LOUIS XIII Limited Edition Diwali Decanter Celebration - 182
- Brookfield Kolter Land Partners debuts Solaeris master-planned community in Port St. Lucie - 162
- Simpalm Staffing Launches Tax Preparer Staffing for U.S. CPA Firms - 160
- David Weekley Homes' Atlanta Division Has Third Forsyth County Community in the Works - 151
- Canada's First Data Lakehouse Goes Global in Banking: Nabil Bank Becomes Nepal's First Bank to Implement a True Agentic Lakehouse Platform, DataNature - 148
- Commercial Manufacturing Validation Completed as November 10 FDA Milestone Approaches; Critical FDA Milestone Close: NRx Pharmaceuticals NAS DAQ: NRXP - 130
Similar on Rezul
- Boston Industrial Solutions Introduces the New Volta® M100 Pad Printing Machine
- What If the Greatest Gift This Holiday Season Came in a Dream of Your Loved One in Spirit?
- Scoop Social Co. Brings Its Signature Mobile Dessert Experience to Minneapolis
- Record Q3 Revenue and Gross Profit Delivered: Revenue Surges 40%, Gross Margin Soars to 36% & Adjusted EBITDA Loss Narrows 64% for Cycurion, Inc $CYCU
- Inaugural 12 Trees of Christmas gala raises $525,000 for DMG research and family support
- Entrepreneur Nouho M Kanneh Talks Family, Faith and a $37 Million Portfolio in New Interview
- Massive Acquisition Into Defense With STS for Virtuix Holdings; $40 Million Revenue Business Will Accelerate Growth Transforming Market Position
- Commercial Sales for U.S.-Made, Preservative-Free Ketamine Amid Long-Runnin Shortage Following FDA Approval by NRx Pharmaceuticals, Inc
- Security Planning Tips For Your Holiday Event From Access Patrol Services
- Contracting Resources Group Receives 2026 HIRE Vets Platinum Medallion Award
Longevity Academy Features Gail Humble, MD of KLOTHO SKIN in the Longevity Leaders Project
Rezul News/10749416
Dr. Humble presents The Science of Skin Longevity. Founder and CEO of KLOTHO SKIN discusses the Klotho longevity protein, regenerative skincare, clinical research, and the future of health.
BELLEVUE, Wash. - Rezul -- Longevity Academy recently welcomed Dr. Gail Humble, founder and CEO of KLOTHO SKIN and co-founder of Klotho Longevity, to the Longevity Leaders Project, an ongoing interview series exploring the people, organizations, and scientific breakthroughs shaping the future of human longevity.
The conversation explored the growing body of research surrounding the Klotho gene and protein, their potential role in cellular aging, and how KLOTHO SKIN is applying this science to regenerative skincare.
Dr. Humble has been studying the Klotho protein for nearly three decades. With a background in genetics and regenerative aesthetics, she became interested in its potential shortly after the gene was first identified in 1997.
Originally studied for its relationship to aging and age-related diseases, Klotho has since attracted growing attention for its involvement in cellular protection, oxidative stress regulation, and multiple biological pathways associated with healthy aging.
During the interview, Dr. Humble explained how Klotho protein levels generally decline with age and why researchers are increasingly interested in understanding whether maintaining or increasing these levels could help support healthier aging.
More on Rezul News
Rather than simply addressing visible signs of aging, KLOTHO SKIN is investigating how cellular processes associated with aging might be influenced through regenerative skincare.
A central focus of the discussion was the company's clinical research. Dr. Humble presented findings from laboratory studies and three human clinical studies evaluating skincare formulations containing Klotho protein and growth factors derived from conditioned stem cell media.
In one laboratory study, treated cells demonstrated a 40% reduction in DNA strand damage following ultraviolet exposure compared with controls.
Dr. Humble also highlighted findings from the company's human studies, including reported improvements in photodamage, skin texture, wrinkles, dryness, and uneven pigmentation. In a 16-patient study involving a layered skincare regimen over four months, researchers reported a 47.5% reduction in photodamage and a 61% reduction in dryness.
The discussion also explored the relationship between skin aging and biological aging throughout the body. Dr. Humble emphasized that skin is more than a cosmetic concern. As the body's largest organ, it plays essential roles in protection, immune function, temperature regulation, and overall health.
The conversation covered several key topics:
Looking ahead, Dr. Humble discussed Klotho Longevity's interest in developing an oral Klotho protein supplement, while acknowledging the scientific and delivery challenges involved. She also described emerging research into other approaches designed to influence Klotho activity.
More on Rezul News
The interview highlighted an important shift taking place within longevity science: growing interest in addressing the biological mechanisms of aging rather than focusing exclusively on its visible effects or individual age-related conditions.
For Dr. Humble, protecting skin health is an important part of that broader mission.
Watch the full interview: https://longevityacademy.us/dr-humble-klotho-skin/
The conversation explored the growing body of research surrounding the Klotho gene and protein, their potential role in cellular aging, and how KLOTHO SKIN is applying this science to regenerative skincare.
Dr. Humble has been studying the Klotho protein for nearly three decades. With a background in genetics and regenerative aesthetics, she became interested in its potential shortly after the gene was first identified in 1997.
Originally studied for its relationship to aging and age-related diseases, Klotho has since attracted growing attention for its involvement in cellular protection, oxidative stress regulation, and multiple biological pathways associated with healthy aging.
During the interview, Dr. Humble explained how Klotho protein levels generally decline with age and why researchers are increasingly interested in understanding whether maintaining or increasing these levels could help support healthier aging.
More on Rezul News
- Law Offices of Larry E. Bray, P.A. Wins Fourth District Appeal Clarifying Limits of Florida's Offer of Judgment Statute
- Sale of Eaglecrest Master-Planned Community in Crandall, Texas Completes
- The Secret Sale Is On at O'Dwyer Homes
- Holiday Magic Returns to Downtown Downers Grove November 27-29
- What If the Greatest Gift This Holiday Season Came in a Dream of Your Loved One in Spirit?
Rather than simply addressing visible signs of aging, KLOTHO SKIN is investigating how cellular processes associated with aging might be influenced through regenerative skincare.
A central focus of the discussion was the company's clinical research. Dr. Humble presented findings from laboratory studies and three human clinical studies evaluating skincare formulations containing Klotho protein and growth factors derived from conditioned stem cell media.
In one laboratory study, treated cells demonstrated a 40% reduction in DNA strand damage following ultraviolet exposure compared with controls.
Dr. Humble also highlighted findings from the company's human studies, including reported improvements in photodamage, skin texture, wrinkles, dryness, and uneven pigmentation. In a 16-patient study involving a layered skincare regimen over four months, researchers reported a 47.5% reduction in photodamage and a 61% reduction in dryness.
The discussion also explored the relationship between skin aging and biological aging throughout the body. Dr. Humble emphasized that skin is more than a cosmetic concern. As the body's largest organ, it plays essential roles in protection, immune function, temperature regulation, and overall health.
The conversation covered several key topics:
- How Dr. Gail Humble became interested in the Klotho gene and protein and began researching its potential nearly 30 years ago
- The relationship between Klotho protein levels, cellular aging, oxidative stress, and age-related diseases
- How KLOTHO SKIN is applying regenerative science to support skin health and address visible signs of aging
- Findings from laboratory and human clinical studies evaluating Klotho based skincare formulations
- The potential connection between skin aging, biological age, and overall healthspan
- The importance of exercise, sleep, stress management, and other lifestyle factors in supporting healthy aging
- Emerging research involving Klotho supplementation, gene-based technologies, and future longevity interventions
- How regenerative dermatology may evolve as researchers better understand the biological mechanisms of aging
Looking ahead, Dr. Humble discussed Klotho Longevity's interest in developing an oral Klotho protein supplement, while acknowledging the scientific and delivery challenges involved. She also described emerging research into other approaches designed to influence Klotho activity.
More on Rezul News
- Austin Housing Market: Hays County Pending Sales Rise 10.6% as Metro Prices Fall 6.9%
- Lakeview 55+ at Tributary Expands Following Phase 1 Sellout
- Scoop Social Co. Brings Its Signature Mobile Dessert Experience to Minneapolis
- LGF Lab Gas Flow Launches Fully Automatic Laboratory Gas Changeover Manifold System with Ultra High Purity Gas Regulator Valve
- Woodside Village Joins Corner Property Management Following CMP Acquisition
The interview highlighted an important shift taking place within longevity science: growing interest in addressing the biological mechanisms of aging rather than focusing exclusively on its visible effects or individual age-related conditions.
For Dr. Humble, protecting skin health is an important part of that broader mission.
Watch the full interview: https://longevityacademy.us/dr-humble-klotho-skin/
Source: Longevity Academy
0 Comments
Latest on Rezul News
- Niceville, Shalimar and Fort Walton Beach Sellers: Buyers Have Plenty of Homes to Choose From
- Rates at an 18-year high and values falling: why 1 July 2027 puts new land in focus
- Spencer Buys Houses Expands Cash Home Buying Services in Memphis to Help Local Homeowners
- Turkish Engineer Who Cracked Wall Street's Algorithm Launches Hermes AI Analyzer
- UK Financial Ltd Launches MayaSwap On MAYA CHAIN To Facilitate UKFLMS-For-Gold Swaps, Officially Transforming UKFLMS From Meme Into A Real-World Asset
- CRMLS Bars AI Landscaping in Listing Photos, Label or Not
- Entrepreneur Nouho M Kanneh Talks Family, Faith and a $37 Million Portfolio in New Interview
- Emerald Williams Selected to Super Lawyers Rising Stars 2022-2026
- ClearLead Digital Launches New Website for Red Roof Rentals & Real Estate
- Massive Acquisition Into Defense With STS for Virtuix Holdings; $40 Million Revenue Business Will Accelerate Growth Transforming Market Position
- Orlando Real Estate Broker Bent Danholm Wins 2026 Goody Business Book Award for The Architecture of Demand
- Commercial Sales for U.S.-Made, Preservative-Free Ketamine Amid Long-Runnin Shortage Following FDA Approval by NRx Pharmaceuticals, Inc
- The King Returns: Satirical December 2026 Rematch Sees Challenger Delayed by a Christmas Light Installation
- JasonFox.me Announces Agent Command Center, an AI Toolkit for Real Estate Agents
- Canadian Publisher Announces the Release of 'Real Estate & Your Style as a Thought Leader' Book
- A Minnesota sheriff's sale is usually not move-out day, Midwest Home Co. reminds homeowners
- LCH2 Awarded Additional $1 Million to Advance Lewis County Clean Energy Campus
- Crypto Friendly Cleveland Firm ACC Solutions Helps Buyers Anywhere Rehab and Manage Property
- Security Planning Tips For Your Holiday Event From Access Patrol Services
- Apple Valley Home Prices Rise 12% to $461,500 in October 2026 as Closed Sales Decline 12.9%

